Skip to main content
The Bright Side
arrow_backHome
Doctors at "Exteza": the treatment that lowered the risk of death for lung cancer patients
Health
Ynet HealthHE
October 24, 2026

Doctors at "Exteza": the treatment that lowered the risk of death for lung cancer patients

In an international study involving 563 patients with small-cell lung cancer, it was found that a combined treatment with two drugs reduced the risk of death by 58%. Median survival jumped from 12.7 months with the existing treatment to 21.1 months with the new treatment. The astronomical price list for the drug in the U.S.: more than 1.2 million shekels per year. Prof. Ido Wolf from Ichilov: "Amazing results, bordering on the crazy"

Read More
translateRead translated

Automatic translation by Google

Curated from Ynet Health. Classified as Health by AI, which sometimes makes mistakes.

Why are you reporting this article?

Why are you reporting this article?
0/500

More like this

More ›